Tom Bahrami

Tom Bahrami serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements validation and solicitation development to contract award and administration. He plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) and agency procurement policies, with a primary focus on scientific and technical services. His portfolio centers on research and development contracts, particularly in the life sciences and engineering domains, where he facilitates the acquisition of innovative solutions through competitive bidding, sole-source justifications, and other authorized procurement methods. Bahrami’s work supports mission-critical R&D initiatives requiring specialized technical expertise and rigorous oversight. While no specific contractor relationships are currently identifiable, Bahrami routinely engages with a diverse pool of vendors, including research institutions, independent laboratories, and technology firms specializing in biotechnology and life sciences. His contracting patterns reflect a preference for open competition, with minimal reliance on single-source awards, indicating a commitment to market transparency and fair opportunity. He collaborates closely with technical representatives and program managers to align contract terms with scientific objectives and performance metrics. Bahrami’s contracting activity is overwhelmingly non-set-aside, with 87.8% of awards issued under unrestricted competition. However, he consistently allocates 12.2% of his portfolio to Total Small Business Set-Asides under FAR 19.5, demonstrating a deliberate and structured commitment to small business participation. He does not currently utilize 8(a), HUBZone, or SDVOSB set-asides, but his use of total small business set-asides reflects a strategic effort to foster innovation through agile, nimble vendors capable of delivering specialized R&D services. His procurement focus is heavily concentrated in NAICS 541714 (Biotechnology R&D), accounting for 82% of his activity, followed by NAICS 541712 and 541715, which cover broader physical, engineering, and life sciences research. He primarily acquires contract research, laboratory services, clinical trial support, and analytical instrumentation development, reflecting deep expertise in scientific procurement and technical requirements definition within high-compliance, innovation-driven environments.